Jon Morgan
Foot & Ankle Surgery · Wichita, KSNPI 1114130747
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 32.4% of the total. Reporting peaked in 2019 at $379 and has fallen 54.6% since, to $172 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in KS, where the typical reported total is $2,742.
Across 89 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$435
- Amgen$242
- Organogenesis Inc.$141
- Melinta Therapeutics, LLC$103
- Biowound Solutions, Inc.$79
- Stryker$73
- plus $272 from 9 others
What the payments were for
- Food & beverage$1,345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 19 | $435 |
| Amgen | 40 | $242 |
| Organogenesis Inc. | 9 | $141 |
| Melinta Therapeutics, LLC | 1 | $103 |
| Biowound Solutions, Inc. | 3 | $79 |
| Stryker(2 entities) | 3 | $73 |
| Johnson & Johnson(2 entities) | 3 | $65 |
| Vertex | 2 | $61 |
| Heron Therapeutics, Inc. | 2 | $29 |
| Paragon 28, Inc. | 2 | $27 |
| Bioventus LLC | 1 | $21 |
| Osiris Therapeutics Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Kerecis Limited | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orbactiv$103
How this compares
$1,345 in reported general payments places this provider in the 30th percentile of 40 foot & ankle surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 11 | $124 |
| Clindamycin Hcl | 14 | $87 |
| Gabapentin | 15 | $76 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $56 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Wichita
- John FanningWichita$6K
- David SanchezWichita$6K
- Shawn MorrowWichita$3K
- Steven HowellWichita$2K
- Kent HeadyWichita$799
- Greg HortonKansas City$1.1M
- Melissa JournotLeawood$26K
- Zhipeng YangKansas City$25K
- Patrick McGregorLawrence$24K
- Andrea DrielingHutchinson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.